Quiescent cancer cells (QCCs) reversibly reside in G 0 phase, thus allowing them to survive chemotherapy and radiotherapy, which generally target proliferating cells. Surviving QCCs may re-proliferate, consequently result progression, recurrence, metastasis. Therefore, understanding the key players governing QCC survival activation is crucial for developing QCC-targeting agents. This review pre...